The first drug ever generated by artificial intelligence has entered Phase 2 clinical trials with lung disease patients; the first dose was successfully administered to a human, Insilico Medicine announced.
In the traditional process, he said, scientists find targets by combing through scientific literature andCEO Alex Zhavoronkov, PhD , in the company's
In this case, Insilico used AI both to discover a new target for IPF and then to generate a new molecule that could act on that target. "Essentially, our scientists provided Chemistry42 with the specific characteristics they were looking for and the system generated a series of possible molecules, ranked based on their likelihood of success," Zhavoronkov said.
The Insilico team is hopeful the data from this newly launched clinical trial will confirm their drug’s safety and effectiveness. "Our initial studies have indicated that INS018_055 has the potential to address some of the limitations of current therapies."The Insilico team is hopeful the data from this newly launched clinical trial will confirm the drug’s safety and effectiveness."If our Phase IIa study is successful, the drug will then go to Phase IIb with a larger cohort of participants," said Hong Kong-based Sujata Rao, M.D., Insilico’s chief medical officer, in a statement to Fox News Digital.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
AI-discovered drug enters Phase II trials, first patients dosed in the US, ChinaAI can be leveraged to bring down the time and money spent on the drug discovery process, shortening time to treatment availability and improving chances of success.
Read more »
ECB faces new phase of lingering inflation, says LagardeEuro zone inflation has entered a new phase which could linger for some time, European Central Bank President Christine Lagarde said on Tuesday, outlining a lengthy fight against price growth that must dampen demand and force firms to curb prices.
Read more »
The Phase One XC is a $62,490 Fixed-Lens, Medium Format Travel CameraPhase One's new XC Camera is a new travel-friendly all-in-one medium-format system that is the company’s most compact digitally integrated camera ever. Given the asking price, it's safe to say the audience for it will be... niche.
Read more »
Single Molecule Infrared Spectroscopy in the Gas Phase - NatureNature research paper: Single Molecule Infrared Spectroscopy in the Gas Phase
Read more »
Phase separation of FSP1 promotes ferroptosis - NatureAn inhibitor of the ferroptosis-suppressing FSP1 induces phase separation of FSP1, thereby impairing its function and reducing tumour growth.
Read more »